BioInvent International (Sweden) Performance
| BINV Stock | SEK 44.55 1.20 2.62% |
On a scale of 0 to 100, BioInvent International holds a performance score of 5. The firm shows a Beta (market volatility) of -0.46, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning BioInvent International are expected to decrease at a much lower rate. During the bear market, BioInvent International is likely to outperform the market. Please check BioInvent International's total risk alpha, treynor ratio, and the relationship between the jensen alpha and sortino ratio , to make a quick decision on whether BioInvent International's price patterns will revert.
Risk-Adjusted Performance
5 of 100
Weak | Strong |
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in BioInvent International AB are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, BioInvent International unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 729.3 M | |
| Total Cashflows From Investing Activities | -467.5 M |
BioInvent |
BioInvent International Relative Risk vs. Return Landscape
If you would invest 3,940 in BioInvent International AB on August 25, 2024 and sell it today you would earn a total of 515.00 from holding BioInvent International AB or generate 13.07% return on investment over 90 days. BioInvent International AB is generating 0.2629% of daily returns and assumes 3.9949% volatility on return distribution over the 90 days horizon. Simply put, 35% of stocks are less volatile than BioInvent, and 95% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
BioInvent International Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for BioInvent International's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as BioInvent International AB, and traders can use it to determine the average amount a BioInvent International's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0658
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | BINV | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.99 actual daily | 35 65% of assets are more volatile |
Expected Return
| 0.26 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
| 0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average BioInvent International is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of BioInvent International by adding it to a well-diversified portfolio.
BioInvent International Fundamentals Growth
BioInvent Stock prices reflect investors' perceptions of the future prospects and financial health of BioInvent International, and BioInvent International fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on BioInvent Stock performance.
| Return On Equity | -0.0274 | |||
| Return On Asset | -0.0192 | |||
| Profit Margin | (0.14) % | |||
| Operating Margin | (0.16) % | |||
| Current Valuation | 1.16 B | |||
| Shares Outstanding | 65.8 M | |||
| Price To Earning | (9.49) X | |||
| Price To Book | 1.40 X | |||
| Price To Sales | 7.25 X | |||
| Revenue | 19.38 M | |||
| EBITDA | (263.32 M) | |||
| Cash And Equivalents | 28.46 M | |||
| Cash Per Share | 0.08 X | |||
| Total Debt | 21.53 M | |||
| Debt To Equity | 22.00 % | |||
| Book Value Per Share | 25.92 X | |||
| Cash Flow From Operations | (245.84 M) | |||
| Earnings Per Share | (4.55) X | |||
| Total Asset | 1.45 B | |||
| Current Asset | 56 M | |||
| Current Liabilities | 28 M | |||
About BioInvent International Performance
Assessing BioInvent International's fundamental ratios provides investors with valuable insights into BioInvent International's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the BioInvent International is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
BioInvent International AB focuses on the research and development of immunomodulating antibodies for the treatment of cancer in Sweden, Europe, and internationally. The Company was founded in 1997 and is based in Lund, Sweden. BioInvent International operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 68 people.Things to note about BioInvent International performance evaluation
Checking the ongoing alerts about BioInvent International for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for BioInvent International help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| BioInvent International had very high historical volatility over the last 90 days | |
| The company reported the revenue of 19.38 M. Net Loss for the year was (278.44 M) with profit before overhead, payroll, taxes, and interest of 19.38 M. | |
| BioInvent International AB has accumulated about 28.46 M in cash with (245.84 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.08. | |
| Roughly 57.0% of the company shares are held by institutions such as insurance companies |
- Analyzing BioInvent International's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether BioInvent International's stock is overvalued or undervalued compared to its peers.
- Examining BioInvent International's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating BioInvent International's management team can have a significant impact on its success or failure. Reviewing the track record and experience of BioInvent International's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of BioInvent International's stock. These opinions can provide insight into BioInvent International's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for BioInvent Stock Analysis
When running BioInvent International's price analysis, check to measure BioInvent International's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioInvent International is operating at the current time. Most of BioInvent International's value examination focuses on studying past and present price action to predict the probability of BioInvent International's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioInvent International's price. Additionally, you may evaluate how the addition of BioInvent International to your portfolios can decrease your overall portfolio volatility.